drugset / Trial / NCT00141336

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

NCT00141336

Phase 3 Completed 750 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the long-term safety and tolerability of pregabalin in patients with partial seizures.

Timeline

Start
1999-11
Primary completion
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule

Indications